Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
8
AIRS Quote, Financials, Valuation and Earnings
Last price:
$1.89
Seasonality move
:
-32.77%
Day range:
$1.78 - $1.92
52-week range:
$1.53 - $12.00
Dividend yield:
0%
P/E ratio:
300.71x
P/S ratio:
0.71x
P/B ratio:
1.43x
Volume:
585.5K
Avg. volume:
1.4M
1-year change:
-67.75%
Market cap:
$117.4M
Revenue:
$180.4M
EPS (TTM):
-$0.30
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AIRS
AirSculpt Technologies, Inc.
|
$43.1M | $0.01 | -10.84% | -65.36% | $6.00 |
|
CVS
CVS Health Corp.
|
$100B | $1.83 | 1.11% | 59.17% | $94.84 |
|
FPCG
First Physicians Capital Group, Inc.
|
-- | -- | -- | -- | -- |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- |
|
VYND
Vynleads, Inc.
|
-- | -- | -- | -- | -- |
|
WORX
SCWorx Corp.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AIRS
AirSculpt Technologies, Inc.
|
$1.88 | $6.00 | $117.4M | 300.71x | $0.00 | 0% | 0.71x |
|
CVS
CVS Health Corp.
|
$76.69 | $94.84 | $97.6B | 55.43x | $0.67 | 3.47% | 0.24x |
|
FPCG
First Physicians Capital Group, Inc.
|
$1,025.00 | -- | $10M | -- | $0.00 | 0% | 1.42x |
|
UNVC
UNIVEC
|
$0.0025 | -- | $453K | -- | $0.00 | 0% | -- |
|
VYND
Vynleads, Inc.
|
$0.39 | -- | $7.1M | -- | $0.00 | 0% | -- |
|
WORX
SCWorx Corp.
|
$0.43 | -- | $6.7M | -- | $0.00 | 0% | 0.63x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AIRS
AirSculpt Technologies, Inc.
|
51.18% | 10.736 | 17.19% | 0.22x |
|
CVS
CVS Health Corp.
|
51.53% | -0.370 | 79.13% | 0.48x |
|
FPCG
First Physicians Capital Group, Inc.
|
-- | 0.000 | -- | -- |
|
UNVC
UNIVEC
|
-- | 1.393 | -- | -- |
|
VYND
Vynleads, Inc.
|
-66.58% | -2.323 | 1.42% | 0.10x |
|
WORX
SCWorx Corp.
|
0.05% | 2.106 | 0.08% | 1.15x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AIRS
AirSculpt Technologies, Inc.
|
$16.9M | -$1.3M | -10.01% | -21.8% | -3.72% | -$405K |
|
CVS
CVS Health Corp.
|
$13.6B | $2.3B | 1.1% | 2.28% | 2.19% | $2.6B |
|
FPCG
First Physicians Capital Group, Inc.
|
-- | -- | -- | -- | -- | -- |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- | -- |
|
VYND
Vynleads, Inc.
|
$4K | -$56.6K | -- | -- | -- | -$14K |
|
WORX
SCWorx Corp.
|
$119.1K | -$138.9K | -74.13% | -74.77% | -19.68% | -$358.1K |
AirSculpt Technologies, Inc. vs. Competitors
-
Which has Higher Returns AIRS or CVS?
CVS Health Corp. has a net margin of -27.18% compared to AirSculpt Technologies, Inc.'s net margin of 2.77%. AirSculpt Technologies, Inc.'s return on equity of -21.8% beat CVS Health Corp.'s return on equity of 2.28%.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies, Inc.48.33% -$0.15 $168.2M CVSCVS Health Corp.12.82% $2.30 $155.3B -
What do Analysts Say About AIRS or CVS?
AirSculpt Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 219.15%. On the other hand CVS Health Corp. has an analysts' consensus of $94.84 which suggests that it could grow by 23.67%. Given that AirSculpt Technologies, Inc. has higher upside potential than CVS Health Corp., analysts believe AirSculpt Technologies, Inc. is more attractive than CVS Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies, Inc.0 2 0 CVSCVS Health Corp.16 5 0 -
Is AIRS or CVS More Risky?
AirSculpt Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.496, suggesting its less volatile than the S&P 500 by 50.368%.
-
Which is a Better Dividend Stock AIRS or CVS?
AirSculpt Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.47% to investors and pays a quarterly dividend of $0.67 per share. AirSculpt Technologies, Inc. pays 3.05% of its earnings as a dividend. CVS Health Corp. pays out 191.23% of its earnings as a dividend. AirSculpt Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CVS Health Corp.'s is not.
-
Which has Better Financial Ratios AIRS or CVS?
AirSculpt Technologies, Inc. quarterly revenues are $35M, which are smaller than CVS Health Corp. quarterly revenues of $105.7B. AirSculpt Technologies, Inc.'s net income of -$9.5M is lower than CVS Health Corp.'s net income of $2.9B. Notably, AirSculpt Technologies, Inc.'s price-to-earnings ratio is 300.71x while CVS Health Corp.'s PE ratio is 55.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies, Inc. is 0.71x versus 0.24x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies, Inc.0.71x 300.71x $35M -$9.5M CVSCVS Health Corp.0.24x 55.43x $105.7B $2.9B
-
Which has Higher Returns AIRS or FPCG?
First Physicians Capital Group, Inc. has a net margin of -27.18% compared to AirSculpt Technologies, Inc.'s net margin of --. AirSculpt Technologies, Inc.'s return on equity of -21.8% beat First Physicians Capital Group, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies, Inc.48.33% -$0.15 $168.2M FPCGFirst Physicians Capital Group, Inc.-- -- -- -
What do Analysts Say About AIRS or FPCG?
AirSculpt Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 219.15%. On the other hand First Physicians Capital Group, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that AirSculpt Technologies, Inc. has higher upside potential than First Physicians Capital Group, Inc., analysts believe AirSculpt Technologies, Inc. is more attractive than First Physicians Capital Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies, Inc.0 2 0 FPCGFirst Physicians Capital Group, Inc.0 0 0 -
Is AIRS or FPCG More Risky?
AirSculpt Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Physicians Capital Group, Inc. has a beta of 0.522, suggesting its less volatile than the S&P 500 by 47.813%.
-
Which is a Better Dividend Stock AIRS or FPCG?
AirSculpt Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AirSculpt Technologies, Inc. pays 3.05% of its earnings as a dividend. First Physicians Capital Group, Inc. pays out -- of its earnings as a dividend. AirSculpt Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AIRS or FPCG?
AirSculpt Technologies, Inc. quarterly revenues are $35M, which are larger than First Physicians Capital Group, Inc. quarterly revenues of --. AirSculpt Technologies, Inc.'s net income of -$9.5M is higher than First Physicians Capital Group, Inc.'s net income of --. Notably, AirSculpt Technologies, Inc.'s price-to-earnings ratio is 300.71x while First Physicians Capital Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies, Inc. is 0.71x versus 1.42x for First Physicians Capital Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies, Inc.0.71x 300.71x $35M -$9.5M FPCGFirst Physicians Capital Group, Inc.1.42x -- -- --
-
Which has Higher Returns AIRS or UNVC?
UNIVEC has a net margin of -27.18% compared to AirSculpt Technologies, Inc.'s net margin of --. AirSculpt Technologies, Inc.'s return on equity of -21.8% beat UNIVEC's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies, Inc.48.33% -$0.15 $168.2M UNVCUNIVEC-- -- -- -
What do Analysts Say About AIRS or UNVC?
AirSculpt Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 219.15%. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that AirSculpt Technologies, Inc. has higher upside potential than UNIVEC, analysts believe AirSculpt Technologies, Inc. is more attractive than UNIVEC.
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies, Inc.0 2 0 UNVCUNIVEC0 0 0 -
Is AIRS or UNVC More Risky?
AirSculpt Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UNIVEC has a beta of -0.101, suggesting its less volatile than the S&P 500 by 110.112%.
-
Which is a Better Dividend Stock AIRS or UNVC?
AirSculpt Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AirSculpt Technologies, Inc. pays 3.05% of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend. AirSculpt Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AIRS or UNVC?
AirSculpt Technologies, Inc. quarterly revenues are $35M, which are larger than UNIVEC quarterly revenues of --. AirSculpt Technologies, Inc.'s net income of -$9.5M is higher than UNIVEC's net income of --. Notably, AirSculpt Technologies, Inc.'s price-to-earnings ratio is 300.71x while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies, Inc. is 0.71x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies, Inc.0.71x 300.71x $35M -$9.5M UNVCUNIVEC-- -- -- --
-
Which has Higher Returns AIRS or VYND?
Vynleads, Inc. has a net margin of -27.18% compared to AirSculpt Technologies, Inc.'s net margin of --. AirSculpt Technologies, Inc.'s return on equity of -21.8% beat Vynleads, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies, Inc.48.33% -$0.15 $168.2M VYNDVynleads, Inc.-- -$0.00 -$195.7K -
What do Analysts Say About AIRS or VYND?
AirSculpt Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 219.15%. On the other hand Vynleads, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that AirSculpt Technologies, Inc. has higher upside potential than Vynleads, Inc., analysts believe AirSculpt Technologies, Inc. is more attractive than Vynleads, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies, Inc.0 2 0 VYNDVynleads, Inc.0 0 0 -
Is AIRS or VYND More Risky?
AirSculpt Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Vynleads, Inc. has a beta of 5.424, suggesting its more volatile than the S&P 500 by 442.416%.
-
Which is a Better Dividend Stock AIRS or VYND?
AirSculpt Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vynleads, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AirSculpt Technologies, Inc. pays 3.05% of its earnings as a dividend. Vynleads, Inc. pays out -- of its earnings as a dividend. AirSculpt Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AIRS or VYND?
AirSculpt Technologies, Inc. quarterly revenues are $35M, which are larger than Vynleads, Inc. quarterly revenues of --. AirSculpt Technologies, Inc.'s net income of -$9.5M is lower than Vynleads, Inc.'s net income of -$58.1K. Notably, AirSculpt Technologies, Inc.'s price-to-earnings ratio is 300.71x while Vynleads, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies, Inc. is 0.71x versus -- for Vynleads, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies, Inc.0.71x 300.71x $35M -$9.5M VYNDVynleads, Inc.-- -- -- -$58.1K
-
Which has Higher Returns AIRS or WORX?
SCWorx Corp. has a net margin of -27.18% compared to AirSculpt Technologies, Inc.'s net margin of -185.96%. AirSculpt Technologies, Inc.'s return on equity of -21.8% beat SCWorx Corp.'s return on equity of -74.77%.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies, Inc.48.33% -$0.15 $168.2M WORXSCWorx Corp.16.88% -$0.15 $6M -
What do Analysts Say About AIRS or WORX?
AirSculpt Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 219.15%. On the other hand SCWorx Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that AirSculpt Technologies, Inc. has higher upside potential than SCWorx Corp., analysts believe AirSculpt Technologies, Inc. is more attractive than SCWorx Corp..
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies, Inc.0 2 0 WORXSCWorx Corp.0 0 0 -
Is AIRS or WORX More Risky?
AirSculpt Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SCWorx Corp. has a beta of 2.149, suggesting its more volatile than the S&P 500 by 114.918%.
-
Which is a Better Dividend Stock AIRS or WORX?
AirSculpt Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AirSculpt Technologies, Inc. pays 3.05% of its earnings as a dividend. SCWorx Corp. pays out -- of its earnings as a dividend. AirSculpt Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AIRS or WORX?
AirSculpt Technologies, Inc. quarterly revenues are $35M, which are larger than SCWorx Corp. quarterly revenues of $705.8K. AirSculpt Technologies, Inc.'s net income of -$9.5M is lower than SCWorx Corp.'s net income of -$1.3M. Notably, AirSculpt Technologies, Inc.'s price-to-earnings ratio is 300.71x while SCWorx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies, Inc. is 0.71x versus 0.63x for SCWorx Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies, Inc.0.71x 300.71x $35M -$9.5M WORXSCWorx Corp.0.63x -- $705.8K -$1.3M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
